Interferon and ribavirin versus interferon and amantadine in interferon nonresponders with chronic hepatitis C

American Journal of Gastroenterology

Volumn 95, Issue 5, 2000, Pages 1284-1289

  Khalili, Mandana ^a   Denham, Cheryl ^a   Perrillo, Robert ^a,b  

^a OCHSNER MEDICAL CENTER   (United States)

^b OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2B INTERFERON; AMANTADINE; RIBAVIRIN; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBIOTIC THERAPY; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VIRUS LOAD;

EID: 0034097487     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)00817-0     Document Type: Article

References (22)

1. M.J Tong N.S El-Farra A.R Reikes Clinical outcomes after transfusion-associated hepatitis C N Engl J Med 332 1995 1463 1466
2. Seeff LB. Natural history of hepatitis C. Hepatology 1997;26(suppl 1):21–8S.
3. Hoofnagle JH, Tralka TS. National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis C. Hepatology 1997;26(suppl 1):2–10S.
4. McHutchison JG, Gordon SC, Schiff ER, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998;339:1485–2.
5. G.L Davis R Esteban-Mur V Rustgi Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C N Engl J Med 339 1998 1493 1499
6. O Reichard G Norkrans A Fryden Randomised, double-blind, placebo-controlled trial of interferon alpha 2b with, and without ribavirin for chronic hepatitis C Lancet 351 1998 83 87
7. J.P Smith Treatment of chronic hepatitis C with amantadine Dig Dis Sci 42 1997 1681 1687
8. A Olmeda M Khalili R.P Perrillo Amantadine monotherapy in patients with chronic hepatitis C Gastroenterology 114 1998 A1316
9. N Pimstone A Yu M Akhondi End-of-treatment response of chronic hepatitis with either amantadine or rimantadine Hepatology 26 1997 A217 (abstract)
10. S Brillanti M Foli L Gramantieri Triple antiviral therapy for chronic hepatitis C in interferon alfa non-responders A pilot randomized controlled study Hepatology 26 1997 367A (abstract)
11. J.A Findor J.R Daruich E Bruch Igartua Amantadine HCL alone, and associated with recombinant alpha IFN 2a during a short term therapy in chronic HCV infection Hepatology 26 1997 217A
12. J.C Fang E.E Hespenheide C.J Driscoll Amantadine-HCL treatment of chronic hepatitis C Hepatology 26 1997 217A
13. S.W Schalm B.E Hansen L Chemello Ribavirin enhances the efficacy but not the adverse effects on interferon in chronic hepatitis C Meta-analysis of individual patient data from European centers J Hepatol 26 1997 961 966
14. J.L Brown Efficacy of combined interferon and ribavirin for treatment of hepatitis C Lancet 351 1998 78 79
15. S Brillanti M Miglioli L Barbara Combined antiviral therapy with ribavirin and interferon alfa in interferon alfa relapsers and non-responders Italian experience J Hepatol 23 suppl 2 1995 13 16
16. R Schvarcz Y Ando A Sonnerborg Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone Swedish experience J Hepatol 23 suppl 2 1995 17 21
17. S Brillanti J Garson M Foli A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C Gastroenterology 107 1994 812 817
18. Reichard O, Schvarcz R, Weiland O. Therapy of hepatitis C: Alpha interferon and ribavirin. Hepatology 1997;26(suppl 1):108–11S.
19. M.L Shiffman Use of high-dose interferon in the treatment of chronic hepatitis C Semin Liver Dis 19 1999 25 33
20. J.J Skehel A.J Hay J.A Armstrong On the mechanism of inhibition of influenza virus replication by amantadine hydrochloride J Gen Virol 38 1978 97 110
21. F.G Hayden A.N Schlepushkin N.L Pushkarskaya Combined interferon-a2, rimantadine hydrochloride, and ribavirin inhibition of influenza virus replication in vitro Antimicrob Agents Chemother 25 1984 53 57
22. Davis GL, Lau JYN. Factors predictive of beneficial response to therapy of hepatitis C. J Hepatology 1997;26(suppl 1):122–7S.